MediWound Ltd. announced the appointment of Aharon Yaari to the company's Board of Directors. With this change, the company's Board of Directors increases to seven members, while the composition of the Board's committees remain unchanged. Since 2015, Mr. Yaari has served as a director of Clal Biotechnology Industries Ltd.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.96 USD | -3.72% | -2.54% | +65.68% |
03-21 | MediWound Ltd. Provides Revenue Guidance for the Year 2025 and 2026 | CI |
03-21 | Transcript : MediWound Ltd., Q4 2023 Earnings Call, Mar 21, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+65.68% | 163M | |
-1.62% | 89.22B | |
+1.32% | 40.49B | |
-15.54% | 32.79B | |
+64.13% | 26.23B | |
-22.06% | 14.52B | |
-7.72% | 13.09B | |
-44.07% | 11.6B | |
-13.06% | 11.5B | |
+4.94% | 8.82B |
- Stock Market
- Equities
- MDWD Stock
- News MediWound Ltd.
- MediWound Ltd. Appoints Aharon Yaari to its Board of Directors